aptiganel has been researched along with Stroke in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, PA; Buchan, AM; Hill, MD; Hoyte, L | 1 |
Albers, GW; Goldstein, LB; Hall, D; Lesko, LM | 1 |
Becker, KJ; Tirschwell, DL | 1 |
Birmingham, K | 1 |
Albers, GW; Goldstein, LB | 1 |
Sareen, D | 1 |
2 review(s) available for aptiganel and Stroke
Article | Year |
---|---|
The rise and fall of NMDA antagonists for ischemic stroke.
Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanidines; Humans; Indoles; Ischemia; N-Methylaspartate; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Stroke | 2004 |
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
1 trial(s) available for aptiganel and Stroke
Article | Year |
---|---|
Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Guanidines; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Survival Analysis; Time Factors | 2001 |
3 other study(ies) available for aptiganel and Stroke
Article | Year |
---|---|
Ensuring patient safety in clinical trials for treatment of acute stroke.
Topics: Clinical Trials as Topic; Fibrinolytic Agents; Guanidines; Humans; Neuroprotective Agents; Risk; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2001 |
Future of neuroprotective drugs in doubt.
Topics: Clinical Trials as Topic; Excitatory Amino Acid Antagonists; Guanidines; Humans; Multicenter Studies as Topic; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Stroke; Tissue Plasminogen Activator | 2002 |
Patient safety in trials of therapy for acute ischemic stroke.
Topics: Brain Ischemia; Clinical Trials as Topic; Guanidines; Humans; Neuroprotective Agents; Safety; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |